ConductScience.org, home

Paper35580932

Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma.

Pinjusic K and 6 others. J Immunother Cancer, 2022. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma. Papers, record 35580932. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35580932

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma.
PubMed
Journal
J Immunother Cancer
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
2.09
iCite
Revised in PubMed
2022-07-16
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pinjusic KKatarinahttps://orcid.org/0000-0002-5070-3340
2Dubey OAOlivier Andreas
3Egorova OOlga
4Nassiri SSina
5Meylan EEtienne
6Faget JJulienhttps://orcid.org/0000-0003-0848-7135
7Constam DBDaniel Beat

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ActivinsMajor topic
MelanomaMajor topic
Animals
CD8-Positive T-Lymphocytes
Humans
Immunity, Cellular
Inhibin-beta Subunits
Mice
Proto-Oncogene Proteins B-raf

Source PubMed

Download CSV of topics

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130540228Activin A in Mammalian Physiology.Physiol Rev2019https://conductscience.org/library/papers/30540228PubMed
232916126Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma.Cancer Cell2020https://conductscience.org/library/papers/32916126PubMed
317982055CD8 T cell help for innate antitumor immunity.J Immunol2007https://conductscience.org/library/papers/17982055PubMed
429483207Impact of Chemical-Induced Mutational Load Increase on Immune Checkpoint Therapy in Poorly Responsive Murine Tumors.Mol Cancer Ther2018https://conductscience.org/library/papers/29483207PubMed
533182504CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4.Int J Mol Sci2020https://conductscience.org/library/papers/33182504PubMed
624798330Nodal·Gdf1 heterodimers with bound prodomains enable serum-independent nodal signaling and endoderm differentiation.J Biol Chem2014https://conductscience.org/library/papers/24798330PubMed
712364468Overexpression of wild-type activin receptor alk4-1 restores activin antiproliferative effects in human pituitary tumor cells.J Clin Endocrinol Metab2002https://conductscience.org/library/papers/12364468PubMed
827287723The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations.Pigment Cell Melanoma Res2016https://conductscience.org/library/papers/27287723PubMed
919288218Regulatory expression of genes related to metastasis by TGF-beta and activin A in B16 murine melanoma cells.Mol Biol Rep2010https://conductscience.org/library/papers/19288218PubMed
1031636098Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.Clin Cancer Res2020https://conductscience.org/library/papers/31636098PubMed
1129643229T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.Sci Transl Med2018https://conductscience.org/library/papers/29643229PubMed
1228844941Paracrine Activin-A Signaling Promotes Melanoma Growth and Metastasis through Immune Evasion.J Invest Dermatol2017https://conductscience.org/library/papers/28844941PubMed
1327364554BAFF and APRIL from Activin A-Treated Dendritic Cells Upregulate the Antitumor Efficacy of Dendritic Cells In Vivo.Cancer Res2016https://conductscience.org/library/papers/27364554PubMed
1428486109Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.Cancer Cell2017https://conductscience.org/library/papers/28486109PubMed
1529312797Loss of ACVRIB leads to increased squamous cell carcinoma aggressiveness through alterations in cell-cell and cell-matrix adhesion proteins.Am J Cancer Res2017https://conductscience.org/library/papers/29312797PubMed
1615196700Activin isoforms signal through type I receptor serine/threonine kinase ALK7.Mol Cell Endocrinol2004https://conductscience.org/library/papers/15196700PubMed
1731570880Tumour-intrinsic resistance to immune checkpoint blockade.Nat Rev Immunol2020https://conductscience.org/library/papers/31570880PubMed
1819293190Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment.Cancer Res2009https://conductscience.org/library/papers/19293190PubMed
191899424Inhibin and activin modulate human monocyte chemotaxis and human lymphocyte interferon-gamma production.J Clin Endocrinol Metab1991https://conductscience.org/library/papers/1899424PubMed
2015520172CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease.Cancer Res2004https://conductscience.org/library/papers/15520172PubMed

See all 50 referencesDownload CSV of references

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
42951965Tumour assembloids recapitulate tumour-CAF-T cell crosstalk in renal cancer.Nature2026https://conductscience.org/library/papers/42951965PubMed
42595443Deficiency in circulating T cells in four core genotypes mice with Sry translocation.J Immunol2026https://conductscience.org/library/papers/42595443PubMed
41985061A bio-inspired computational pipeline for antibody screening and repurposing.Brief Bioinform2026https://conductscience.org/library/papers/41985061PubMed
41463203Sex Differences in the Response to Lung Cancer and Its Relation to Programmed Cell Death Protein-1/Programmed Death-Ligand-1 Checkpoint Therapies.Cancers (Basel)2025https://conductscience.org/library/papers/41463203PubMed
41116748Single-Cell RNA Sequencing Identifies Accumulation of Fcgr2b + Virtual Memory-Like CD8 T Cells With Cytotoxic and Inflammatory Potential in Aged Mouse White Adipose Tissue.Aging Cell2025https://conductscience.org/library/papers/41116748PubMed
41102920Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity.Mol Oncol2026https://conductscience.org/library/papers/41102920PubMed
41091425Pan-cancer analysis of INHBA indicates its potential prognostic value and correlation with HNSC and LIHC.Discov Oncol2025https://conductscience.org/library/papers/41091425PubMed
41054626Sirp-α Antibody Inhibits Renal Cell Carcinoma Progression via Akt1/Akt2 Modulation in Tumor-Associated Macrophages.J Inflamm Res2025https://conductscience.org/library/papers/41054626PubMed
40872475Tumor Microenvironmental Dynamics in Shaping Resistance to Therapeutic Interventions in Melanoma: A Narrative Review.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40872475PubMed
40303343Sex bias in tumor immunity: insights from immune cells.Theranostics2025https://conductscience.org/library/papers/40303343PubMed
40075112Activin A affects colorectal cancer progression and immunomodulation in a stage dependent manner.Sci Rep2025https://conductscience.org/library/papers/40075112PubMed
40064965Kallikrein-8 mediates furin-independent Activin-A precursor processing to stimulate tumor growth in melanoma.Nat Commun2025https://conductscience.org/library/papers/40064965PubMed
39837814Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells.Signal Transduct Target Ther2025https://conductscience.org/library/papers/39837814PubMed
39727149Activin A promoted the anti-tumor effect of ActRIIA high CD8+ T cells in mouse hepatoma.Cancer Med2025https://conductscience.org/library/papers/39727149PubMed
39448726Stepwise release of Activin-A from its inhibitory prodomain is modulated by cysteines and requires furin coexpression to promote melanoma growth.Commun Biol2024https://conductscience.org/library/papers/39448726PubMed
39253924Activin A-Targeted Therapy in Cancer: An Updated Review on Challenges and Opportunities in Clinical Translation.Curr Pharm Des2026https://conductscience.org/library/papers/39253924PubMed
39223366INHBA promotes tumor growth and induces resistance to PD-L1 blockade by suppressing IFN-γ signaling.Acta Pharmacol Sin2025https://conductscience.org/library/papers/39223366PubMed
39223291Activin A plays an essential role in migration and proliferation of hepatic stellate cells via Smad3 and calcium signaling.Sci Rep2024https://conductscience.org/library/papers/39223291PubMed
38893071Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling.Cancers (Basel)2024https://conductscience.org/library/papers/38893071PubMed
38727264Activin A, a Novel Chemokine, Induces Mouse NK Cell Migration via AKT and Calcium Signaling.Cells2024https://conductscience.org/library/papers/38727264PubMed

See all 28 cited byDownload CSV of cited by

Genes31

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACVR1B91PubTator's text mininghttps://conductscience.org/library/genes/91NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
CCL116356PubTator's text mininghttps://conductscience.org/library/genes/6356NCBI Gene
CCL176361PubTator's text mininghttps://conductscience.org/library/genes/6361NCBI Gene
CCL226367PubTator's text mininghttps://conductscience.org/library/genes/6367NCBI Gene
CCR41233PubTator's text mininghttps://conductscience.org/library/genes/1233NCBI Gene
CCR51234PubTator's text mininghttps://conductscience.org/library/genes/1234NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CDKN2A1029PubTator's text mininghttps://conductscience.org/library/genes/1029NCBI Gene
CSF1R1436PubTator's text mininghttps://conductscience.org/library/genes/1436NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
CXCL103627PubTator's text mininghttps://conductscience.org/library/genes/3627NCBI Gene
CXCL94283PubTator's text mininghttps://conductscience.org/library/genes/4283NCBI Gene
CXCR32833PubTator's text mininghttps://conductscience.org/library/genes/2833NCBI Gene
FOXP350943PubTator's text mininghttps://conductscience.org/library/genes/50943NCBI Gene
GZMB3002PubTator's text mininghttps://conductscience.org/library/genes/3002NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL43565PubTator's text mininghttps://conductscience.org/library/genes/3565NCBI Gene
INHBA3624PubTator's text mininghttps://conductscience.org/library/genes/3624NCBI Gene

See all 31 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35580932

GET https://conductscience.org/api/papers/v1/35580932/references?page=2